Navigation Links
Shengtai Pharmaceutical, Inc. Reports Unaudited Third Quarter Fiscal 2009 Financial Results
Date:5/15/2009

or more information about Shengtai Pharmaceutical, Inc., please visit http://www.shengtaipharmaceutical.com .

Forward-looking Statements

Certain statements made in this news release, may contain forward-looking statements concerning the Company's business and products. These statements include, without limitation, statements regarding our ability to prepare the Company for growth, the Company's planned capacity expansion and predictions and guidance relating to the Company's future financial performance. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs, but they involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These factors may include, but are not limited to, such factors as unanticipated changes in product demand especially in the pharmaceutical industry, pricing and demand trends for the Company's products, changes to government regulations, risk associated with operation of the Company's new facilities, risk associated with large-scale implementation of the Company's business plan, the ability to attract new customers, ability to increase its products' applications, cost of raw materials, downturns in the Chinese economy, and other information detailed from time to time in the Company's filings and future filings with the United States Securities and Exchange Commission. Investors are urged to consider these factors carefully in evaluating the forward-looking statements herein and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by this cautionary statement. The forward-looking statements mad
'/>"/>

SOURCE Shengtai Pharmaceutical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Shengtai Pharmaceutical Schedules 2009 Third Quarter Financial Results and Conference Call
2. Shengtai Pharmaceutical Hosts Key Customers at Its Headquarters for Facility Tour and Technology Exchange Conference
3. Shengtai Pharmaceutical, Inc. Comments On Its Operations
4. Shengtai Pharmaceutical Schedules 2009 Second Quarter Financial Results and Conference Call
5. Shengtai Pharmaceutical, Inc. Comments on Chinas Recently Approved Health Care Reform Plan
6. Shengtai Pharmaceutical to Present at Roth 21st Annual OC Growth Stock Conference
7. Shengtai Pharmaceutical Expands International Sales Program
8. Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008
9. Shengtai Pharmaceutical, Inc. Announces Conference Call to Discuss Third Quarter Results of Fiscal Year 2008
10. Shengtai Pharmaceutical, Inc. Reports Strong Second Quarter Results of Fiscal Year 2008
11. Shengtai Pharmaceutical, Inc. to Present at Roth Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...ers from the North Pole, Textsanta.net lets parent...a , North Pole, AK (PRWEB...cies at the North Pole Santa Claus has added SMS t...lobe informed of his Christmas progress at the Nor...tment have identified a large and growing percenta...
(Date:11/26/2009)...Ennis, P.A. is offering free nationwide confidenti... control pills who have suffered a Deep Vein Throm...ack or other related cardiac issues or had their G...800-856-6405 or go to the firm’s website at ...ase evaluation form. , (P...
(Date:11/25/2009)...swire/-SentinelleMedicalInc.,aleadingmanufacturero...algaryScientificInc.,aleadingproviderofsoftwareena...(TM)Breast4DAdvancedVisualizationsoftware. ,, T...tWebclientbasedmedicalimagingofferinginthemarket.C...-footprintaccess-requiringnosoftwaredownload,andru...
(Date:11/25/2009)...SNewswire/--TheBlackAIDSInstituterecentlyheldBoard...or2010. ,, ThenewBoardMembersareahighlydiverseg...ance,governmenthealthprograms,editorial,andbusines...fpersonalbackgroundsincludingbothheterosexualandga...epresentingmultipleagegroups. ,, (Photo: http:/...
(Date:11/25/2009)... statistically significant survival benefit from a...ceptor (ER)-positive tumors had high levels of pho...S118-P), according to a brief communication publis...onal Cancer Institute . , Approximately 50% of b...inical studies have shown that ER-alpha S118-P is ...
Breaking Medicine News(10 mins):Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2
... human welfare, spread of infectious disease and f...atellite imagery in order to acquire the proper ba...in, the geography professor of Kansas State Univer... Doug Goodin uses remote sensing, in combinati...
...ate University, Doug Goodin, makes use of satellit...and cover //changes on human health and food secur...with other types of data, to monitor and predict t... Decisions about Human Welfare," which was sponsor...
... have been able to zero in (on) the modalities of ... and other types of diseases. // Clinical trials o...drug to reduce the potency of a key enzyme, in cha...nn Collegiate Professor of Chemistry at U-M. 'Ou...
...ecialist, NHS can be freed from its’ problems, if ..., are reconsidered before they are implemented. //...vatization plan may make matters worse for the dep...ce has deteriorated. Though plans of privatization...
... the launch of BARACLUDE? (entecavir) for the tre...llowing its approval by the Drug Controller Genera...ed for the treatment of chronic hepatitis B virus ...histologically active disease. BARACLUDE? is...
... are repeatedly failing to implement rules that wi...atients //from contaminated surgical instruments. ...keeping instruments in sets so they can be traced ...to see that surgical instruments were not contamin...
Other Medicine News:Health News:Ecological Changes affects human health, food security 2Health News:Satellite Imagery to monitor the Social Impact Of Geographical Changes 2Health News:Autoimmune disorders studied in detail by U-M researchers. 2Health News:India Approves Baraclude? (entecavir) For ,Treatment Of Chronic HEPATITIS B 2
(Date:11/25/2009)...RNewswire-FirstCall/--Abaxis,Inc.(Nasdaq: ABAX ),a...oodanalysissystems,announcedtodaythatClintSeverson...21stAnnualPiperJaffrayHealthCareConferenceonWednes...heldattheNewYorkPalaceHotelinNewYorkCity. ,, A...rketsportablebloodanalysissystemsforuseinanyveteri...
(Date:11/25/2009)...Newswire/--CempraPharmaceuticalsInc.todayannounced...eofficer,willpresentatthePiperJaffray21stAnnualHea...eNewYorkPalaceHotelinNewYorkCity.Dr.Fernandeswillp...clinicalprogramsforthetreatmentofdrug-resistantpat...cals ,, Foundedin2006,CempraPharmaceuticalsisa...
(Date:11/25/2009)...,Nov.25/PRNewswire-FirstCall/--HeartWareInternatio...ndprovideroflessinvasive,miniaturizedcirculatorysu...ncedheartfailure,todayannouncedthatitisscheduledto...rayHealthCareConferenceat8:00amESTonWednesday,Dece...aceHotel,December1-2. ,, AlivewebcastoftheCompa...
Breaking Medicine Technology:Electrocardiogram Blip Signals Heart Trouble 49820 1Electrocardiogram Blip Signals Heart Trouble 49820 2Electrocardiogram Blip Signals Heart Trouble 49820 3Connextions Inc Strengthens Technology Capabilities with Addition of Highly Regarded IT Executive 49816 1Connextions Inc Strengthens Technology Capabilities with Addition of Highly Regarded IT Executive 49816 2Connextions Inc Strengthens Technology Capabilities with Addition of Highly Regarded IT Executive 49816 3Children 26apos 3Bs National Medical Center Honors The Children 26apos 3Bs Cancer Foundation for Commitment to Area Kids 49812 1Children 26apos 3Bs National Medical Center Honors The Children 26apos 3Bs Cancer Foundation for Commitment to Area Kids 49812 2Children 26apos 3Bs National Medical Center Honors The Children 26apos 3Bs Cancer Foundation for Commitment to Area Kids 49812 3
...NESS WIRE)--Jun 11, 2007 - Neurogen,Corporation (N...us,Phase 1 clinical studies for NG2-73, the Compan...ere presented today at the SLEEP,2007 Annual Meeti...(APSS) in Minneapolis, Minnesota. Two Phase 2b cli...ents are currently being,conducted by the Company....
...pact of Insomnia on Healthcare System and,Worker P...FirstCall/ -- Neurocrine,Biosciences, Inc. announc...s on the impact of chronic primary and transient,i... Professional,Sleep Societies (APSS) Annual Meetin...ntly under-diagnosed and puts a significant,strain...
Other Medicine Technology:Neurogen Proprietary Insomnia Compound Data Presented at Associated,Professional Sleep Societies Annual Meeting 2Neurogen Proprietary Insomnia Compound Data Presented at Associated,Professional Sleep Societies Annual Meeting 3Neurogen Proprietary Insomnia Compound Data Presented at Associated,Professional Sleep Societies Annual Meeting 4Neurocrine Biosciences Announces New Research Studies Presented at,APSS Reveal Significant Under-Diagnosis of Insomnia 2Neurocrine Biosciences Announces New Research Studies Presented at,APSS Reveal Significant Under-Diagnosis of Insomnia 3Neurocrine Biosciences Announces New Research Studies Presented at,APSS Reveal Significant Under-Diagnosis of Insomnia 4Neurocrine Biosciences Announces New Research Studies Presented at,APSS Reveal Significant Under-Diagnosis of Insomnia 5
Anti-MPO - ELISA (P-ANCA)
Myeloperoxidase (MPO) Enzyme-Linked Immunosorbent Assay (ELISA)
Iso-Insulin ELISA
RIDASCREEN Anti-RSV IgM Assay
Medicine Products: